Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI)

Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, Wolf W, Fietkau R, Gaipl U, Frey B (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Strahlentherapie und Onkologie Urban & Vogel

Book Volume: 194

Pages Range: S199-S200

Authors with CRIS profile

Markus Hecht Department of Radiation Oncology Anna-Jasmina Donaubauer Department of Radiation Oncology Sandra Rutzner Department of Radiation Oncology Marlen Haderlein Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie Udo Gaipl Department of Radiation Oncology Benjamin Frey Department of Radiation Oncology

How to cite

APA:

Hecht, M., Donaubauer, A.-J., Harrer, A., Rutzner, S., Becker, I., Lettmaier, S.,... Frey, B. (2018). Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI). (pp. S199-S200).

MLA:

Hecht, Markus, et al. "Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI)." 2018. S199-S200.

BibTeX: Download